Leerink Partners cuts Cytokinetics target price to $100 from $103
CYTK•Leerink Partners cut its target price for Cytokinetics to $100 from $103.
Related News
Colombia's Tecnoglass Q3 profit beats estimates on strong demand
TGLS•
Amplitude, Inc.: Raymond James raises target price to $22 from $13
AMPL•
Viridian Therapeutics target price raised to $42 from $39 by Truist Securities
VRDN•
Core Natural Resources raises 2026 high-calorific-value thermal coal cash cost guidance to $40-$41 per ton
CNR•
1stDibs Q3 revenue rises 5%, net loss narrows
DIBS•